A Sleeping Beauty screen reveals NF-kB activation in CLL mouse model
Open Access
- 23 May 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 121 (21), 4355-4358
- https://doi.org/10.1182/blood-2013-02-486035
Abstract
TCL1 oncogene is overexpressed in aggressive form of human chronic lymphocytic leukemia (CLL) and its dysregulation in mouse B cells causes a CD5-positive leukemia similar to the aggressive form of human CLLs. To identify oncogenes that cooperate with Tcl1, we performed genetic screen in Eμ−TCL1 mice using Sleeping Beauty transposon-mediated mutagenesis. Analysis of transposon common insertion sites identified 7 genes activated by transposon insertions. Overexpression of these genes in mouse CLL was confirmed by real time reverse transcription-polymerase chain reaction. Interestingly, the main known function of 4 of 7 genes (Nfkb1, Tab2, Map3K14, and Nfkbid) is participation in or activation of the nuclear factor-kB (NF-kB) pathway. In addition, activation of the NF-kB is 1 of main functions of Akt2, also identified in the screen. These findings demonstrate cooperation of Tcl1 and the NF-kB pathway in the pathogenesis of aggressive CLL. Identification cooperating cancer genes will result in the development of combinatorial therapies to treat CLL. Key Points Tcl1 cooperates with the NF-kB pathway in the pathogenesis of the aggressive form of CLL.Keywords
This publication has 21 references indexed in Scilit:
- Molecular basis of CLLSeminars in Cancer Biology, 2010
- Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLLProceedings of the National Academy of Sciences, 2008
- Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RARαBlood, 2008
- Role of nuclear IκB proteins in the regulation of host immune responsesJournal of Infection and Chemotherapy, 2008
- Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by miR-29 and miR-181Cancer Research, 2006
- Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon systemNature, 2005
- Inhibition of JNK by Cellular Stress- and Tumor Necrosis Factor α-induced AKT2 through Activation of the NFκB Pathway in Human Epithelial CellsJournal of Biological Chemistry, 2002
- TAB2, a Novel Adaptor Protein, Mediates Activation of TAK1 MAPKKK by Linking TAK1 to TRAF6 in the IL-1 Signal Transduction PathwayMolecular Cell, 2000
- MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1Nature, 1997
- Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha.Proceedings of the National Academy of Sciences, 1991